Skip to main content
. 2012 Apr 18;2012(4):CD003869. doi: 10.1002/14651858.CD003869.pub3

Kurtz 1981

Methods RCT: enrolled: 309 evaluated: 255
Participants Inclusion: 1. Cancer patients with positive isotope brain scans 2. No evidence of disseminated disease Exclusion: 1. NFC IV 2. Anti‐cancer treatment within previous 2 wks 3. Progressive untreated primary
Interventions 5000 cGy/20 fr versus 3000 cGy/10 fr
Outcomes 1. Survival 2. Median time to progression 3. Palliation of symptoms (4. Improvement rate) (5. Cause of death)
Notes QS = 3